View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wiese Edward A
(Last) (First) (Middle)
T. ROWE PRICE GROUP, INC.
100 E. PRATT STREET
(Street)
BALTIMORE MD 21202
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2015 		3. Issuer Name and Ticker or Trading Symbol
PRICE T ROWE GROUP INC [ TROW ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 140,640.301 D
Common Stock 12,281 I Spouse
Common Stock 76,000.277 I Wiese EA Family 2012 Trust
Common Stock 38,000 I Wiese RJ Family 2012 Trust
Common Stock 38,000 I Wiese WS Family 2012 Trust
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) (1) 10/03/2015 Common Stock 3,046 32.118 D
Stock Options (Right to Buy) (2) 11/01/2016 Common Stock 10,155 45.4792 D
Stock Options (Right to Buy) (3) 09/06/2017 Common Stock 8,124 49.2503 D
Stock Options (Right to Buy) (4) 09/04/2018 Common Stock 7,109 56.2017 D
Stock Options (Right to Buy) (5) 02/12/2019 Common Stock 1,645 27.0473 D
Stock Options (Right to Buy) (6) 09/10/2019 Common Stock 4,061 44.4552 D
Stock Options (Right to Buy) (7) 02/18/2020 Common Stock 6,092 48.8368 D
Stock Options (Right to Buy) (8) 09/08/2020 Common Stock 6,093 46.9365 D
Stock Options (Right to Buy) (9) 02/17/2021 Common Stock 6,093 69.2478 D
Stock Options (Right to Buy) (10) 09/08/2021 Common Stock 6,092 49.7721 D
Stock Options (Right to Buy) (11) 02/23/2022 Common Stock 3,046 60.5438 D
Stock Options (Right to Buy) (12) 09/06/2022 Common Stock 3,046 62.3161 D
Stock Options (Right to Buy) (13) 02/21/2023 Common Stock 3,000 71.41 D
Stock Options (Right to Buy) (14) 09/10/2023 Common Stock 3,000 72.04 D
Stock Options (Right to Buy) (15) 02/19/2024 Common Stock 3,000 79.89 D
Stock Options (Right to Buy) (16) 09/09/2024 Common Stock 3,000 80.4 D
Explanation of Responses:
1. 10/03/2005 Grant - The option vests 20% annually over a 5 year period beginning on 10/03/2006.
2. 11/01/2006 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2007.
3. 09/06/2007 Grant - The option vests 20% annually over a 5 year period beginning on 09/06/2008.
4. 09/04/2008 Grant - The option vests 20% annually over a 5 year period beginning on 09/04/2009.
5. 02/12/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.
6. 09/10/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.
7. 02/18/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.
8. 09/08/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.
9. 02/17/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.
10. 09/08/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.
11. 02/23/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.
12. 09/06/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.
13. 02/21/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.
14. 09/10/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.
15. 02/19/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.
16. 09/09/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.
Edward A. Wiese 01/27/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY


THE UNDERSIGNED, Edward A. Wiese, hereby constitutes and appoints,
with full power of substitution, the Chief Executive Officer, the Chairman,
the Vice Chairman, the Chief Financial Officer, the Director of Corporate
Services,the Secretary or Assistant Secretary of the Corporation of
T. Rowe Price Group, Inc. (the "Corporation"), the true and lawful
attorney-in-fact of the undersigned, with full power and authority in the
name of and for and on behalf of the undersigned to execute and file any
Form 4 or Form 5 for the purpose of reporting securities transactions to
the Securities and Exchange Commission under Section 16 of the Securities
Exchange Act of 1934, as amended.

This Power of Attorney is made under, and shall be governed pursuant to,
the laws of the State of Maryland.



Date: 	January 21, 2015          /s/_________________________
 				     Edward A. Wiese